Dr. Susan C. Scott

Dr. Susan Scott is a thoracic medical oncologist with the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center at Sibley Memorial Hospital and Assistant Professor of Oncology at the Johns Hopkins University School of Medicine. Dr. Scott has expertise in thoracic malignancies, including non-small cell lung cancer, small cell lung cancer and pulmonary carcinoid tumors, as well as thymic malignancies. She leads the EGFR and HER2 lung cancer research program for Johns Hopkins. Dr. Scott received her undergraduate education at the University of Oxford, UK and medical doctorate from Yale University. She completed residency at the Cleveland Clinic where she also served as Chief Resident in Internal Medicine. Dr. Scott joined Johns Hopkins Oncology for fellowship training in Baltimore and was recruited to the thoracic oncology program to continue work as a physician and clinical scientist focused in lung cancer. Dr. Scott and her team are committed to providing compassionate and individualized care to their patients, including state-of-the-art therapies and clinical trials. Her research interests include clinical trials in resectable lung cancer, innovative applications of immunotherapy, and novel targeted therapies, especially EGFR- and HER2-mutated lung cancers. Dr. Scott is a member of the American Society of Clinical Oncology (ASCO), the American Association of Cancer Research (AACR), and the International Association for the Study of Lung Cancer (IASLC).

Dr. Scott is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, and EGFR Positive Lung Cancer.

Dr. Scott is board certified in American Board Of Internal Medicine. She is actively involved in clinical research, co-authoring 73 peer reviewed articles.